AI-Powered Corneal Endothelium Analysis
for Objective and Reproducible Assessments

CornAI

The corneal endothelium plays a critical role in maintaining corneal transparency and visual function. Yet assessing endothelial cell health remains a complex and time-consuming task, often relying on manual or semi-automated measurements that are prone to variability.

CornAI leverages advanced image analysis and artificial intelligence to automatically analyze specular microscopy images and generate objective, reproducible, and clinically meaningful endothelial biomarkers.

By transforming corneal images into quantitative data, CornAI helps clinicians, researchers, eye banks, and industry partners improve diagnostic accuracy, standardize evaluations, and support data-driven decision-making.

Turn your endothelial images into actionable clinical insights in seconds, with consistent and reliable results.

From Subjective Evaluation to Quantitative Corneal Biomarkers

Traditional approaches often present limitations:

  • Manual counting is time-consuming
  • Results may vary between operators
  • Longitudinal comparisons can be difficult
  • Large datasets require significant human effort

CornAI helps organizations:

  • Automate endothelial cell analysis
  • Improve measurement reproducibility
  • Standardize corneal assessments
  • Generate objective imaging biomarkers
  • Support clinical decision-making
  • Accelerate research studies
  • Facilitate longitudinal patient monitoring
  • Reduce manual analysis workload

Designed for Corneal Specialists, Researchers and Industry

CornAI combines artificial intelligence, image analysis, and ophthalmology expertise to simplify corneal endothelium evaluation.

Key Capabilities

  • Automated endothelial cell detection
  • Cell density quantification
  • Polymegathism and pleomorphism analysis
  • Morphological characterization
  • Objective image quality assessment
  • Longitudinal follow-up capabilities
  • Standardized quantitative reporting
  • High-throughput image processing
  • AI-assisted decision support
  • Exportable clinical and research metrics

The result is a reliable and scalable solution suitable for both routine clinical practice and advanced research applications.

Who Benefits from CornAI ?

Cornea Specialists &
Ophthalmologists

Obtain objective endothelial metrics to support diagnosis, follow-up, and treatment planning.

Hospitals &
ophthalmology Centers

Standardize endothelial assessments and improve workflow efficiency.

Eye
Banks

Support tissue qualification and quality assessment with reproducible measurements.

Academic &
Research Teams

Generate publication-grade data for corneal and ophthalmology studies.

Pharmaceutical
Companies & CRO’s

Access validated imaging biomarkers for clinical studies and therapeutic development.

From Corneal Images
to Clinical Intelligence

CornAI enables ophthalmology professionals to exploit the full value of specular microscopy data. Whether monitoring endothelial health, evaluating corneal diseases, qualifying donor tissues, or generating endpoints for clinical trials, CornAI transforms image-based assessments into robust, quantifiable information.

From image acquisition to clinical interpretation, CornAI helps deliver more objective, reproducible, and actionable corneal evaluations.

Why Choose CornAI?

  • Fully automated endothelial analysis
  • Objective and reproducible measurements
  • AI-powered cell characterization
  • Standardized quantitative biomarkers
  • Designed for clinical and research environments
  • Supports longitudinal patient monitoring
  • Compatible with modern ophthalmic workflows
  • Built on more than 30 years of ADCIS expertise in image analysis and computer vision

Practical Applications

  • Corneal Endothelium Assessment
  • Endothelial Cell Density Analysis
  • Fuchs Dystrophy Monitoring
  • Post-Surgical Corneal Follow-Up
  • Corneal Research Programs
  • Eye Bank Tissue Evaluation
  • Clinical Trial Imaging Endpoints
  • AI-Assisted Ophthalmic Imaging

Scientifically Validated Performance

Developed in collaboration with leading international ophthalmology experts, CornAI has been scientifically validated through a peer-reviewed publication in the British Journal of Ophthalmology.

The solution automatically analyzes specular microscopy images and delivers standardized corneal endothelial measurements, even in the presence of complex images or pathologies such as Fuchs endothelial corneal dystrophy.

Key Benefits of CornAI

  • Peer-reviewed scientific publication in the British Journal of Ophthalmology
    “Development and validation of a deep learning model for automatic assessment of corneal endothelium”
  • Developed and validated using nearly 900 specular microscopy images from both healthy and pathological corneas, including independent external validation.
  • Automated analysis of 8 key corneal endothelial parameters, including cell density, coefficient of variation, pachymetry, mean cell area, standard deviation, hexagonality, and minimum and maximum cell area.
  • Robust performance across varying image quality levels and in challenging conditions such as Fuchs dystrophy with guttae.
  • Results generated within seconds, with accuracy comparable to reference methods used in clinical practice.
CornAI transforms specular microscopy into reliable quantitative data for clinical research and ophthalmic practice.

See Beyond Cell Counts. Access Meaningful
Corneal Biomarkers.

Scroll to Top